1. Home
  2. CMPX vs INSG Comparison

CMPX vs INSG Comparison

Compare CMPX & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • INSG
  • Stock Information
  • Founded
  • CMPX 2014
  • INSG 1996
  • Country
  • CMPX United States
  • INSG United States
  • Employees
  • CMPX N/A
  • INSG N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • INSG Telecommunications Equipment
  • Sector
  • CMPX Health Care
  • INSG Telecommunications
  • Exchange
  • CMPX Nasdaq
  • INSG Nasdaq
  • Market Cap
  • CMPX 206.3M
  • INSG 230.9M
  • IPO Year
  • CMPX N/A
  • INSG 2000
  • Fundamental
  • Price
  • CMPX $1.49
  • INSG $10.35
  • Analyst Decision
  • CMPX Strong Buy
  • INSG Buy
  • Analyst Count
  • CMPX 4
  • INSG 3
  • Target Price
  • CMPX $13.75
  • INSG $14.33
  • AVG Volume (30 Days)
  • CMPX 422.2K
  • INSG 160.7K
  • Earning Date
  • CMPX 11-12-2024
  • INSG 11-12-2024
  • Dividend Yield
  • CMPX N/A
  • INSG N/A
  • EPS Growth
  • CMPX N/A
  • INSG N/A
  • EPS
  • CMPX N/A
  • INSG N/A
  • Revenue
  • CMPX $850,000.00
  • INSG $207,478,000.00
  • Revenue This Year
  • CMPX N/A
  • INSG $3.60
  • Revenue Next Year
  • CMPX $610.48
  • INSG N/A
  • P/E Ratio
  • CMPX N/A
  • INSG N/A
  • Revenue Growth
  • CMPX N/A
  • INSG 12.59
  • 52 Week Low
  • CMPX $0.77
  • INSG $1.60
  • 52 Week High
  • CMPX $2.34
  • INSG $20.67
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 45.22
  • INSG 34.94
  • Support Level
  • CMPX $1.33
  • INSG $10.18
  • Resistance Level
  • CMPX $1.55
  • INSG $11.87
  • Average True Range (ATR)
  • CMPX 0.12
  • INSG 0.56
  • MACD
  • CMPX -0.00
  • INSG 0.11
  • Stochastic Oscillator
  • CMPX 27.66
  • INSG 14.12

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

Share on Social Networks: